Back to Search

ALLAN SEIBERT, MD

MD

Infectious Disease Physician

NPI: 1780979799IndividualAccepts Medicare

Specialties, Licenses & Credentials

Student in an Organized Health Care Education/Training Program

Student in an Organized Health Care Education/Training Program

Code: 390200000X

4301099075(MI)
Infectious Disease PhysicianPrimary

Internal Medicine — Infectious Disease

Code: 207RI0200X

11235975-1205(UT)

Education

UNIVERSITY OF ALABAMA SCHOOL OF MEDICINE

Class of 2011

Research & Publications (10)

Consuming fructose-sweetened, not glucose-sweetened, beverages increases visceral adiposity and lipids and decreases insulin sensitivity in overweight/obese humans.
PMID 19381015·J Clin Invest·2009
8-other
Feasibility and acceptance of electronic quality of life assessment in general practice: an implementation study.
PMID 19493355·Health Qual Life Outcomes·2009
8-other
Differential phospholipid binding by site 3 and site 4 toxins. Implications for structural variability between voltage-sensitive sodium channel domains.
PMID 15632158·J Biol Chem·2005
8-other
Computer-assisted image analysis of bronchioloalveolar carcinoma.
PMID 15845178·Clin Lung Cancer·2005
6-review
Role of Asn-16 and Ser-19 in anthopleurin B binding. Implications for the electrostatic nature of Na(V) site 3.
PMID 15170345·Biochemistry·2004
4-observational
Arg-14 loop of site 3 anemone toxins: effects of glycine replacement on toxin affinity.
PMID 14661964·Biochemistry·2003
7-preclinical
Efficacy and safety of tifacogin (recombinant tissue factor pathway inhibitor) in severe sepsis: a randomized controlled trial.
PMID 12851279·JAMA·2003
3-trial
Voltage-gated sodium channel toxins: poisons, probes, and future promise.
PMID 12777715·Cell Biochem Biophys·2003
6-review
Separation of plutonium and neptunium species by capillary electrophoresis-inductively coupled plasma-mass spectrometry and application to natural groundwater samples.
PMID 14670034·Anal Chem·2003
8-other
Assessment of the safety of recombinant tissue factor pathway inhibitor in patients with severe sepsis: a multicenter, randomized, placebo-controlled, single-blind, dose escalation study.
PMID 11700399·Crit Care Med·2001
3-trial

Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.

Contact & Hours

Via practice · 2 locations total

Address
1500 E MEDICAL CENTER DR, 3116 TAUBMAN CENTER, SPC 5368
ANN ARBOR, MI 48109

Locations (2)

Practice Location

1500 E MEDICAL CENTER DR, ANN ARBOR, MI
(734) 936-5582

Practice Location

30 N 1900 E RM 4B319, SALT LAKE CITY, UT
(801) 581-8812

Quick Facts

NPI
1780979799
Entity Type
Individual
Gender
Male
Medicare
Accepted
Specialties
2
Locations
2
Years in Practice
15
Publications
10

Are you this provider?

Claim Your Profile